Splenic rupture in a plasma cell leukemia, mobilized with G-CSF for autologous stem cell transplant

2010 ◽  
Vol 25 (4) ◽  
pp. 223-225 ◽  
Author(s):  
Consuelo Funes ◽  
Faustino Garcia-Candel ◽  
Maria Juliana Majado ◽  
Consuelo González-García ◽  
Agueda Bas ◽  
...  
Keyword(s):  
Stem Cell ◽  
Plasma Cell ◽  
Stem Cell Transplant ◽  
Splenic Rupture ◽  
Autologous Stem Cell Transplant ◽  
Plasma Cell Leukemia ◽  
Cell Transplant ◽  
Cell Leukemia

scholarly journals Primary plasma cell leukemia: autologous stem cell transplant in an era of novel induction drugs

2018 ◽  
Vol 54 (7) ◽  
pp. 1089-1093 ◽  
Author(s):  
Lohith Gowda ◽  
Mithun Shah ◽  
Ifra Badar ◽  
Qaiser Bashir ◽  
Nina Shah ◽  
...  
Keyword(s):  
Stem Cell ◽  
Plasma Cell ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Plasma Cell Leukemia ◽  
Cell Transplant ◽  
Cell Leukemia ◽  
Primary Plasma Cell Leukemia

scholarly journals Primary Plasma Cell Leukemia: Stem Cell Transplant in an Era of Novel Induction Drugs

2018 ◽  
Vol 24 (3) ◽  
pp. S260-S261 ◽  
Author(s):  
Lohith Gowda ◽  
Mithun Vinod Shah ◽  
Ifra Badar ◽  
Qaiser Bashir ◽  
Nina Shah ◽  
...  
Keyword(s):  
Stem Cell ◽  
Plasma Cell ◽  
Stem Cell Transplant ◽  
Plasma Cell Leukemia ◽  
Cell Transplant ◽  
Cell Leukemia ◽  
Leukemia Stem Cell ◽  
Primary Plasma Cell Leukemia

scholarly journals Plasma Cell Leukemia: A Review of 3 Cases Managed in Kenya

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Matilda Ong’ondi ◽  
Elizabeth Kagotho
Keyword(s):  
Plasma Cell ◽  
Plasma Cells ◽  
De Novo ◽  
White Blood Cells ◽  
Autologous Stem Cell Transplant ◽  
Plasma Cell Leukemia ◽  
Plasma Cell Dyscrasia ◽  
Cell Transplant ◽  
Cell Leukemia ◽  
Primary Plasma Cell Leukemia

Plasma Cell Leukemia (PCL) is a rare and aggressive form of plasma cell dyscrasia that can arise either de novo (primary plasma cell leukemia) or evolve from previously diagnosed and treated multiple myeloma (secondary PCL). We highlight three clinical cases with very different presentations as a reminder of this diagnosis. The cases also highlight the diversity and variability that cover a patient’s journey that is highly dependent on accessibility based on financial capability and social support. The clinical presentation is more aggressive due to the higher tumour burden and more proliferative tumor cells with cytopenias being profound and more organomegaly. The diagnosis is made based on at least 20% of total white blood cells being circulating plasma cells with a peripheral blood absolute plasma cell count of at least 2 × 109/l. Treatment with novel agents followed by autologous stem cell transplant in those who are transplant eligible leads to better outcomes.

scholarly journals Optimizing Autologous Stem Cell Transplant for High-Risk Patients with Plasma Cell Dyscrasias

2018 ◽  
Vol 24 (3) ◽  
pp. S135
Author(s):  
Ehsan Malek ◽  
Gina Hoffman ◽  
Richard Creger ◽  
Brenda Cooper ◽  
Merle Kolk ◽  
...  
Keyword(s):  
Stem Cell ◽  
High Risk ◽  
Plasma Cell ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant ◽  
High Risk Patients ◽  
Risk Patients ◽  
Plasma Cell Dyscrasias

scholarly journals Patient‐reported outcomes following autologous stem cell transplant for patients with multiple myeloma

eJHaem ◽  
2021 ◽  
Author(s):  
Noa Biran ◽  
Wanting Zhai ◽  
Roxanne E. Jensen ◽  
Jeanne Mandelblatt ◽  
Susan Kumka ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Stem Cell ◽  
Patient Reported Outcomes ◽  
Stem Cell Transplant ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant ◽  
Patient Reported
Sign in / Sign up

Export Citation Format

Share Document